14159 Capital (Gp), Llc
Affiliations
- Large Shareholder at Tranzyme Inc (TZYM), 2012-03-14
- Large Shareholder, Director at Genomic Health Inc (GHDX), 2012-03-09
- Large Shareholder at Xoma Corp (XOMA), 2012-03-09
- Large Shareholder, Director at Ardea Biosciences Inc. (RDEA), 2012-02-03
- Large Shareholder at Pharmacyclics Inc (PCYC), 2012-01-26
- Large Shareholder, Director at Incyte Corp (INCY), 2012-01-18
- Large Shareholder, Director at Synageva Biopharma Corp (GEVA), 2012-01-10
- Large Shareholder at Adolor Corp (ADLR), 2012-01-03
- Large Shareholder at Viropharma Inc (VPHM), 2011-12-16
- Large Shareholder, Director at Seattle Genetics Inc (SGEN), 2011-09-08
- Large Shareholder at Auxilium Pharmaceuticals Inc (AUXL), 2011-08-03
- Large Shareholder at Ap Pharma Inc (APPA), 2011-07-06
- Large Shareholder at Vaxgen Inc (VXGN.OB), 2010-07-29
- Large Shareholder at Biocryst Pharmaceuticals Inc (BCRX), 2009-06-01
- Large Shareholder at Allos Therapeutics Inc (ALTH), 2009-02-06
Insider Trading: Purchases See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
TZYM | $3.01 | 910 | Large Shareholder | 57,704 | 2012-03-14 | Filing | |
TZYM | $2.99 | 1,482 | Large Shareholder | 56,794 | 2012-03-14 | Filing | |
TZYM | $2.96 | 4,186 | Large Shareholder | 55,312 | 2012-03-13 | Filing | |
TZYM | $2.55 | 15,076 | Large Shareholder | 51,126 | 2012-03-12 | Filing | |
TZYM | $2.34 | 8,628 | Large Shareholder | 36,050 | 2012-03-12 | Filing |
Insider Trading: Sales See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
AUXL | $17.25 | 1,001 | Large Shareholder | 132,889 | 2011-08-02 | Filing | |
AUXL | $18.04 | 9,678 | Large Shareholder | 133,890 | 2011-08-01 | Filing | |
AUXL | $18.03 | 6,400 | Large Shareholder | 143,568 | 2011-08-01 | Filing | |
ADLR | $1.18 | 884 | Large Shareholder | 186,272 | 2010-10-29 | Filing | |
ADLR | $1.19 | 2,086 | Large Shareholder | 187,156 | 2010-10-28 | Filing |